Business
CLN Maturity Date
CLN Maturity Date.
About this update from Rome Resources Plc
[{"type":"text","content":"\n \n \n \n RNS Number : 4074E\n Pathfinder Minerals Plc\n 05 November 2020\n \n \n \n \n 5 November 2020\n \n \n Pathfinder Minerals Plc\n \n \n (\"Pathfinder\" or the \"Company\")\n \n \n \n CLN Maturity Date\n \n \n \n \n \n Following a review of documentation, Pathfinder advises that its 3 April 2020 announcement regarding the issue of £175,000 Convertible Loan Notes (\"CLN\") noted a maturity date of 1 December 2020, which should have been stated as 11 November 2020.\n \n \n \n \n \n As noted in the Company's announcement on 19 October 2020, the outstanding CLN principal is £77,000, and the amended interest due to 11 November 2020 is £4,556.\n \n \n \n \n \n Please refer to the Company's 3 April 2020 announcement for the full terms of the CLN.\n \n \n \n \n \n Enquiries: \n \n \n \n \n \n Pathfinder Minerals Plc\n \n \n Peter Taylor, Chief Executive Officer\n \n \n Tel. \n +44 (0)20 3143 6748\n \n \n \n \n \n Strand Hanson Limited (Nominated & Financial Adviser and Broker)\n \n \n James Spinney / Ritchie Balmer / Jack Botros\n \n \n Tel. +44 (0)20 7409 3494\n \n \n \n \n \n Vigo Communications (Public Relations)\n \n \n Ben Simons / Simon Woods\n \n \n Tel. +44 (0)20 7390 0234\n \n \n Email. \n \n [email protected]\n \n \n \n \n \n \n Novum Securities Limited (Broker)\n \n \n Colin Rowbury / Jon Belliss\n \n \n Tel. +44 (0)20 7399 9400\n \n \n \n \n \n The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014 (\"MAR\").\n \n \n \n \n \n \n \n \n \n This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS...